[Not Available].
1 Dermatologische Klinik, Universitätsspital Zürich.|2 Dermatologie, Kantonspital Frauenfeld.
Marjam Jeanette
MJ
Barysch
D001913:Bowen's Disease / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D002280:Basal Cell Carcinoma / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D006801:Humans; D055623:Keratosis, Actinic / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D013473:Sunscreening Agents / Q000008:administration & dosage; D014466:Ultraviolet Rays
D013473:Sunscreening Agents
Basalzellkarzinom; Morbus Bowen; Non-Melanoma Skin Cancer (NMSC); actinic keratosis; aktinische Keratose; basal cell carcinoma; bowen’s disease; carcinome basocellulaire; carcinome spinocellulaire; carcinome épidermoide cutané (NMSC); kératose actinique; maladie de Bowen; non-melanoma skin cancer (NMSC); spinozelluläres Karzinom; squamous cell carcinoma